We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J's Marketing Of Risperdal For Children Slammed In Trial

Law360, Philadelphia (October 15, 2015, 6:32 PM EDT) -- Trial in a third case over abnormal breast growth allegedly caused by a Johnson & Johnson unit’s antipsychotic drug got underway on Thursday as a Philadelphia jury heard arguments that the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.